Advertisement
UK markets open in 2 hours 52 minutes

  • NIKKEI 225

    37,698.91
    -761.17 (-1.98%)
     

  • HANG SENG

    17,281.53
    +80.26 (+0.47%)
     

  • CRUDE OIL

    82.88
    +0.07 (+0.08%)
     

  • GOLD FUTURES

    2,325.60
    -12.80 (-0.55%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,549.34
    -1,916.05 (-3.58%)
     

  • CMC Crypto 200

    1,390.33
    -33.77 (-2.37%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

BUZZ-Woodford Patient Capital Trust takes Prothena hit

Reuters - UK Focus

** Shares (Berlin: DI6.BE - news) in Woodford Patient Capital Trust down 4.8 pct, second-biggest faller in the FTSE mid-cap index

** Stock hit by news key early stage pharma holding Prothena , in which the trust holds an 8.56 percent stake, to discontinue Pronto study

** Woodford Investment Management says also held a 2.67 percent stake in its Woodford Equity Income Fund and a 1.65 percent stake in its Woodford Income Focus Fund at end-Feb

** Fund manager Neil Woodford says trial results "undoubtedly a blow" after earlier being increasingly confident it would be successful

** Woodford says to work with company on strategy, points to rest of company's pipeline, technology platform, strong balance sheet as reasons to be optimistic (Simon Jessop)